The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become…
The FDA has denied human testing trials for Neuralink, Elon Musk’s brain-computer interface company. The FDA reportedly raised numerous “deficiencies”…